ARTW

Art's-Way is a $13.9M micro-cap trading around book value (equity $13.3M, ~1.05x book) at 0.6x sales and 13.4x earnings — statistically cheap, and that valuation is the main reason to hold rather than sell. The balance sheet is not in distress: liabilities/equity is a modest 0.69x, debt is small ($2.33M long-term plus $165K current), working capital rose to ~$8.3M and the current ratio improved to 2.30 from 1.98, with $747K still available on the line of credit and ~$4.0M of excess collateral. Management frames the banking relationship as positive and improving as debt is retired.

The headline, though, is misleading. Net income of $1.03M (+237%) sits on top of just $289K of operating income, which actually fell 37.2% — so the earnings surge is driven by items below the operating line, not by the core business improving. The real story is a shrinking, cyclical franchise: revenue has fallen from $30.3M (FY2023) to $24.5M to $23.0M, down 6.2% this year, with the Agricultural Products segment off 13.1% as depressed commodity prices, high borrowing rates and rising input costs squeeze farmer demand. Gross profit fell 14.3% and gross margin compressed to 27.3%; operating margin is a razor-thin 1.3%. The lone bright spot is the Modular Buildings segment, up 4.0% with 'strong profitability.'